Breaking News

GenScript Expands Production Facility in China

Highly automated clean-room facilities offer fast-turnaround, high-purity oligonucleotide, and peptide synthesis service for R&D.

GenScript Biotech Corporation, a provider of life-science research tools and services, expanded its primary manufacturing facility for oligonucleotide and peptide production at Zhenjiang, Jiangsu, China. The expanded oligonucleotide synthesis capability offers qPCR oligos, NGS oligos, RNA oligos, DNA oligos and more to support a wide range of applications—from molecular diagnostics, RNAi, to genome editing. Equipped with high-throughput, large-scale synthesizers, HPLC+ and PAGE+ purification ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters